"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive ...

Although the most common side effect of Electroconvulsive Therapy is memory loss, my recent review suggests that more ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

The robot has provided surgeons with instruments that offer a greater range of movement than in conventional keyhole surgery State-of-the-art robotic surgery has helped improve treatment for ...

Researchers found that transcatheter edge-to-edge repair is just as effective as surgery for patients with secondary mitral regurgitation and had a better safety profile.

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

After 24 months, the group that received the valve repair showed a significant reduction in the rate of recurrent hospitalisations for heart failure or cardiovascular death, compared to the group that ...

The cardiac tissue engineering market is expected to grow from USD 621.2 million in 2024 to USD 1,333.6 million by 2029, ...

The cardiac tissue engineering market is expected to grow from USD 621.2 million in 2024 to USD 1,333.6 million by 2029, reflecting a ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...